Keywords: s-p, vicriviroc, suppresses, hiv, load, through, weeks

S-P's vicriviroc suppresses HIV load through 48 weeks

Article | 18 February 2008

Print This

US drug major Schering-Plough says that final results of a Phase II study showed vicriviroc, its once-daily, next-generation CCR5 HIV ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in